188 related articles for article (PubMed ID: 21199883)
1. Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection.
Fabre V; Wu H; PondTor S; Coutinho H; Acosta L; Jiz M; Olveda R; Cheng L; White ES; Jarilla B; McGarvey ST; Friedman JF; Kurtis JD
J Infect Dis; 2011 Mar; 203(5):707-14. PubMed ID: 21199883
[TBL] [Abstract][Full Text] [Related]
2. New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum.
Liang YJ; Luo J; Yuan Q; Zheng D; Liu YP; Shi L; Zhou Y; Chen AL; Ren YY; Sun KY; Sun Y; Wang Y; Zhang ZS
PLoS One; 2011; 6(5):e20247. PubMed ID: 21629648
[TBL] [Abstract][Full Text] [Related]
3. Effect of maternal praziquantel treatment for Schistosoma japonicum infection on the offspring susceptibility and immunologic response to infection at age six, a cohort study.
Colt S; Jarilla B; Baltazar P; Tallo V; Acosta LP; Wu HW; Barry CV; Kurtis JD; Olveda RM; Friedman JF; Jiz MA
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009328. PubMed ID: 33861768
[TBL] [Abstract][Full Text] [Related]
4. Maternal infection with Schistosoma japonicum induces a profibrotic response in neonates.
McDonald EA; Cheng L; Jarilla B; Sagliba MJ; Gonzal A; Amoylen AJ; Olveda R; Acosta L; Baylink D; White ES; Friedman JF; Kurtis JD
Infect Immun; 2014 Jan; 82(1):350-5. PubMed ID: 24166958
[TBL] [Abstract][Full Text] [Related]
5. Changes of ultrasonography and two serum biochemical indices for hepatic fibrosis in schistosomiasis japonica patients one year after praziquantel treatment.
Cai W; Chen Z; Chen F; Zhou C; Liu R; Wang J
Chin Med J (Engl); 1997 Oct; 110(10):797-800. PubMed ID: 9642313
[TBL] [Abstract][Full Text] [Related]
6. Mini-review: the ultrasonographical and serological changes and their improvement after praziquantel treatment in Schistosoma japonicum infected patients in Leyte, Philippines.
Tanaka M
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():277-80. PubMed ID: 1343908
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing schistosomiasis-induced liver morbidity: implications for global control.
Olveda DU; Inobaya M; Olveda RM; Vinluan ML; Ng SK; Weerakoon K; McManus DP; Ramm GA; Harn DA; Li Y; Lam AK; Guevarra JR; Ross AG
Int J Infect Dis; 2017 Jan; 54():138-144. PubMed ID: 27816660
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis.
Cai P; Mu Y; Olveda RM; Ross AG; Olveda DU; McManus DP
EBioMedicine; 2018 Nov; 37():334-343. PubMed ID: 30482723
[TBL] [Abstract][Full Text] [Related]
9. Serologic and ultrasonographic parameters of praziquantel treatment of hepatic fibrosis in Schistosoma japonicum infection.
Ohmae H; Tanaka M; Nara T; Utsunomiya H; Taguchi H; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1991 Sep; 45(3):350-9. PubMed ID: 1928570
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum.
Chen H; He YW; Liu WQ; Zhang JH
World J Gastroenterol; 2008 May; 14(18):2905-11. PubMed ID: 18473419
[TBL] [Abstract][Full Text] [Related]
11. Expression of Septin4 in Schistosoma japonicum-infected mouse livers after praziquantel treatment.
Zhu D; Song K; Chen J; Wang J; Sun X; Qian H; Gu X; Zhang L; Qin Y; Duan Y
Parasit Vectors; 2015 Jan; 8():19. PubMed ID: 25582427
[TBL] [Abstract][Full Text] [Related]
12. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements.
Li YS; Sleigh AC; Ross AG; Li Y; Williams GM; Tanner M; McManus DP
Trans R Soc Trop Med Hyg; 2000; 94(2):191-7. PubMed ID: 10897367
[TBL] [Abstract][Full Text] [Related]
13. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection.
Coutinho HM; Acosta LP; Wu HW; McGarvey ST; Su L; Langdon GC; Jiz MA; Jarilla B; Olveda RM; Friedman JF; Kurtis JD
J Infect Dis; 2007 Jan; 195(2):288-95. PubMed ID: 17191174
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice.
Ma Z; Liu X; Dong H; Xia D; Wang L; Chen Y; Xiong Y
Parasitol Res; 2018 Sep; 117(9):2831-2839. PubMed ID: 29946766
[TBL] [Abstract][Full Text] [Related]
15. Praziquantel treatment after Schistosoma japonicum infection maintains hepatic insulin sensitivity and improves glucose metabolism in mice.
Luo X; Zhu Y; Liu R; Song J; Zhang F; Zhang W; Xu Z; Hou M; Yang B; Chen L; Ji M
Parasit Vectors; 2017 Oct; 10(1):453. PubMed ID: 28969688
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica.
Hou XY; Ellis MK; McManus DP; Wang YY; Li SD; Williams GM; Li YS
Int J Parasitol; 2011 Mar; 41(3-4):325-32. PubMed ID: 21145322
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection.
Coutinho HM; Leenstra T; Acosta LP; Su L; Jarilla B; Jiz MA; Langdon GC; Olveda RM; McGarvey ST; Kurtis JD; Friedman JF
Am J Trop Med Hyg; 2006 Oct; 75(4):720-6. PubMed ID: 17038701
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of administration of praziquantel on 2 days 2 weeks apart against Schistosoma japonicum eggs in mice.
Hirose Y; Kirinoki M; Matsuda H
Parasitol Int; 2003 Jun; 52(2):141-6. PubMed ID: 12798925
[TBL] [Abstract][Full Text] [Related]
19. Antibody isotype responses to Schistosoma japonicum antigens in subjects from a schistosomiasis area with repeated praziquantel chemotherapy compared with a new endemic zone in Hunan Province, P.R. China.
Li Y; Yu DB; Li YS; Luo XS; Liang YS; Bartley PB; McManus DP
Trans R Soc Trop Med Hyg; 2002; 96(2):210-5. PubMed ID: 12055818
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model.
Shen J; Wang L; Peng M; Liu Z; Zhang B; Zhou T; Sun X; Wu Z
Parasit Vectors; 2019 Sep; 12(1):457. PubMed ID: 31547847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
